Dogukan Koc

Child and Adolescence Psychiatrist
PhD candidate at Generation R, @ErasmusMC
Marie Sklodowska-Curie ESR Fellow @Serotonin_h2020

[JAMA Network Open @JAMANetworkOpen]

Prenatal maternal depressive symptoms were associated increased modularity, global efficiency, and brain connectivity in children from midchildhood to adolescence. https://t.co/pdm0J2nTaC

[Dogukan Koc @DoguKc]

Thanks to our amazing team!
@capp_erasmusmc @ErasmusMC @Serotonin_h2020

[Dogukan Koc @DoguKc]

📢Our new study is out in @JAMANetworkOpen

We examined how maternal depressive symptoms during pregnancy relate to brain network development in children aged 9–15 years
https://t.co/OoOBldKSR3

[Dogukan Koc @DoguKc]

💡 These are population-level findings. We do not claim individual prediction or causality. But they do reinforce why mental health support during pregnancy matters—for both mother and child.

[G. Hazal Koc @antrebea]

🔔Thrilled to share our recent study published in The Journal of Rheumatology, which has been selected as the Editor’s Pick of the month!

📖 Read the full article and 🎥 check our interview with Dr. Proton Rahman at the link below!

[G. Hazal Koc @antrebea]

🚨: Our latest research in @bmj_rmdopen shows minimal radiographic progression in early PsA under current treatment protocols, highlighting the importance of early diagnosis and continuous monitoring.
#PsoriaticArthritis #Rheumatology #Research
https://t.co/nmyCTlk3mK

[Dogukan Koc @DoguKc]

Many thanks to all co-authors: Henning Tiemeier, Bruno Stricker, @ryanmuetzel, and Hanan El Marroun.
@GenerationR_010, @capp_erasmusmc, @ErasmusMC, @Serotonin_h2020

[Dogukan Koc @DoguKc]

🤰💊Exciting findings from our latest study investigating the association of prenatal SSRI exposure and maternal depressive symptoms on offspring white matter development from childhood to adolescence were published in @SOBP
https://t.co/IukFtqvYWF

[Dogukan Koc @DoguKc]

We also want to express our shared concerns regarding the potential for misinterpretation and preemptive clinical implications of our previous study of SSRI use during pregnancy.

Please also read the Comment & Response related to our previous work 👇
https://t.co/TdR4QBL12O

[Dogukan Koc @DoguKc]

@ECNPtweets,@Serotonin_h2020, @capp_erasmusmc, @ErasmusMC, @GenerationR_010

[Dogukan Koc @DoguKc]

Reflecting on the insightful Campfire Session at #ECNP2023—Serotonin and Depression: where do we stand? My commentary offers a critical analysis, addressing methodological aspects, data inclusion, and the nuances of serotonin receptors.https://t.co/Cni35OmpeD

[JAMA @JAMA_current]

New recommendations to screen for perinatal depression multiple times in pregnancy and in the first postpartum year aim to assist with early detection, diagnosis, and treatment.

https://t.co/flYEEZDNv3

[JAMA Psychiatry @JAMAPsych]

Longitudinal population-based research reveals associations between prenatal SSRI exposure and brain development from childhood to adolescence. https://t.co/vnoSMwbeQm

[Dogukan Koc @DoguKc]

Many thanks to all co-authors: Henning Tiemeier, Bruno Stricker, @ryanmuetzel, @HillegersManon and Hanan El Marroun

[Dogukan Koc @DoguKc]

🤰💊🧠 Excited to share our study published in @JAMAPsych, investigating longitudinal links between prenatal SSRI exposure and child brain development. https://t.co/uIOJeFNZSq

[Dogukan Koc @DoguKc]

For many women with prenatal depression, the benefits of antidepressant treatment with SSRI likely outweigh the risks. Yet, determining whether to maintain or cease antidepressant treatment poses a challenge for both clinicians and patients, warranting personalized approaches.